|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
AU628988B2
(en)
|
1989-05-04 |
1992-09-24 |
Wisconsin Alumni Research Foundation |
Method for localization and treatment of tumors and complexes therefor
|
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
|
US5428156A
(en)
|
1993-04-02 |
1995-06-27 |
Associated Universities, Inc. |
Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
|
|
WO1997015599A1
(en)
|
1995-10-27 |
1997-05-01 |
Board Of Regents Of The University Of Nebraska |
Novel acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease
|
|
US7371376B1
(en)
|
1996-10-18 |
2008-05-13 |
Genentech, Inc. |
Anti-ErbB2 antibodies
|
|
JP2001504326A
(ja)
|
1996-10-18 |
2001-04-03 |
ジェネンテック インコーポレーテッド |
抗ＥｒｂＢ２抗体
|
|
WO1998039027A2
(en)
|
1997-03-05 |
1998-09-11 |
John Wayne Cancer Institute |
Sialyl lewis antigens as targets for immunotherapy
|
|
US6913756B1
(en)
|
1998-04-29 |
2005-07-05 |
The Uab Research Foundation |
Monoclonal antibodies specific for anthrax and peptides derived from the antibodies thereof
|
|
US6329503B1
(en)
|
1998-06-01 |
2001-12-11 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US7387772B1
(en)
|
1999-06-22 |
2008-06-17 |
Immunimedics, Inc. |
Chimeric, human and humanized anti-CSAP monoclonal antibodies
|
|
US6787638B1
(en)
|
1998-12-02 |
2004-09-07 |
Applied Molecular Evolution, Inc. |
Tumor specific human monoclonal antibodies and methods of use
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US20020132753A1
(en)
|
2000-01-31 |
2002-09-19 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
IL151865A0
(en)
|
2000-03-31 |
2003-04-10 |
Genentech Inc |
Compositions and methods for detecting and quantifying gene expression
|
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
|
US20040185040A1
(en)
|
2001-11-21 |
2004-09-23 |
Celltech R & D Limited |
Modulating immune responses
|
|
US20040018557A1
(en)
|
2002-03-01 |
2004-01-29 |
Immunomedics, Inc. |
Bispecific antibody point mutations for enhancing rate of clearance
|
|
WO2004022597A1
(ja)
|
2002-09-04 |
2004-03-18 |
Chugai Seiyaku Kabushiki Kaisha |
Gpc3の血中可溶化ｎ端ﾍﾟﾌﾟﾁﾄﾞに対する抗体
|
|
MXPA05001933A
(es)
|
2002-08-19 |
2005-04-28 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
|
CA2525899C
(en)
|
2003-05-09 |
2016-03-08 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
NZ543635A
(en)
|
2003-06-25 |
2008-05-30 |
Crucell Holland Bv |
Human C-type lectin: a suitable target molecule for binding molecules, particularly immunoconjugates, in the diagnosis, prevention and/or treatment of myeloid neoplastic diseases such as AML and CML
|
|
DE10339820A1
(de)
|
2003-08-22 |
2005-03-17 |
Hinzmann, Bernd, Dr. |
Verwendung von an GPR49 bindenden Substanzen zur Diagnose und Behandlung von Krebs
|
|
EP3476861A1
(en)
|
2004-01-07 |
2019-05-01 |
Novartis Vaccines and Diagnostics, Inc. |
M-csf-specific monoclonal antibody and uses thereof
|
|
PT1742966E
(pt)
|
2004-04-22 |
2014-02-05 |
Agensys Inc |
Anticorpos e moléculas derivadas daí que se ligam às proteínas steap-1
|
|
MXPA06014065A
(es)
|
2004-06-01 |
2007-01-31 |
Genentech Inc |
Conjugados de droga-anticuerpo y metodos.
|
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
US20080193376A1
(en)
|
2004-10-28 |
2008-08-14 |
The General Hospital Corporation |
Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation
|
|
WO2006050058A2
(en)
|
2004-10-28 |
2006-05-11 |
The General Hospital Corporation |
Methods of detection and therapy of inflamed tissues using immune modulation
|
|
AU2005304462B2
(en)
|
2004-11-10 |
2011-03-10 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
ES2429340T3
(es)
|
2005-03-10 |
2013-11-14 |
Morphotek, Inc. |
Anticuerpos anti-mesotelina
|
|
EP3058955B1
(en)
|
2005-03-24 |
2019-05-29 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind ov064 and methods of use therefor
|
|
EP1888125A2
(en)
|
2005-04-01 |
2008-02-20 |
Board of Regents of the University of Texas System |
Poly(peptide) as a chelator: methods of manufacture and uses
|
|
CN109485727A
(zh)
|
2005-05-09 |
2019-03-19 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
|
KR101411165B1
(ko)
*
|
2005-07-01 |
2014-06-25 |
메다렉스, 엘.엘.시. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날항체
|
|
US7718369B2
(en)
|
2005-09-12 |
2010-05-18 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
US20070087005A1
(en)
|
2005-10-14 |
2007-04-19 |
Lazar Gregory A |
Anti-glypican-3 antibody
|
|
US7901665B2
(en)
|
2005-11-30 |
2011-03-08 |
General Electric Company |
Conjugated macromolecules
|
|
WO2007109347A2
(en)
|
2006-03-21 |
2007-09-27 |
The Regents Of The University Of California |
N-cadherin and ly6 e: targets for cancer diagnosis and therapy
|
|
CA2652976C
(en)
|
2006-06-02 |
2015-08-11 |
Regeneron Pharmaceuticals, Inc. |
High affinity antibodies to human il-6 receptor
|
|
EP2975057A1
(en)
|
2006-07-10 |
2016-01-20 |
Fujita Health University |
Novel anti-cd73 antibody
|
|
MX2009003938A
(es)
|
2006-10-27 |
2009-04-24 |
Genentech Inc |
Anticuerpos e inmunoconjugados y sus usos.
|
|
AU2007325283B2
(en)
|
2006-11-27 |
2012-08-30 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
US8889100B2
(en)
|
2007-01-11 |
2014-11-18 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
US8545809B2
(en)
|
2007-01-11 |
2013-10-01 |
Immunomedics, Inc. |
Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
|
|
WO2008124467A1
(en)
|
2007-04-06 |
2008-10-16 |
Macrocyclics |
Bifunctional hydroxamic acid ligands and method of synthesis
|
|
CL2008001334A1
(es)
|
2007-05-08 |
2008-09-22 |
Genentech Inc |
Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
|
|
JP5931336B2
(ja)
|
2007-07-02 |
2016-06-08 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
がんを処置および診断するための組成物および方法
|
|
WO2009033011A1
(en)
|
2007-09-07 |
2009-03-12 |
Children's Hospital Medical Center |
Use of secretor, lewis and sialyl antigen levels as predictors for disease
|
|
CN101809162B
(zh)
|
2007-09-28 |
2013-06-05 |
中外制药株式会社 |
血浆中动力学被改善的磷脂酰肌醇蛋白聚糖3抗体
|
|
KR101554753B1
(ko)
|
2007-10-01 |
2015-09-22 |
브리스톨-마이어스 스큅 컴퍼니 |
메소텔린에 결합하는 인간 항체 및 이의 용도
|
|
US8536310B2
(en)
|
2007-10-17 |
2013-09-17 |
Arca Biopharma, Inc. |
Antibodies to CLL-1
|
|
CA2705509A1
(en)
|
2007-11-14 |
2009-05-22 |
Forerunner Pharma Research Co., Ltd. |
Diagnosis and treatment of cancer using anti-gpr49 antibody
|
|
CN104151429B
(zh)
|
2007-11-26 |
2018-07-10 |
拜耳知识产权有限责任公司 |
抗-间皮素抗体及其用途
|
|
TW200938224A
(en)
|
2007-11-30 |
2009-09-16 |
Medarex Inc |
Anti-B7H4 monoclonal antibody-drug conjugate and methods of use
|
|
WO2009099741A1
(en)
|
2008-02-01 |
2009-08-13 |
Genentech, Inc. |
Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
|
|
US8357783B2
(en)
|
2008-03-27 |
2013-01-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Human anti-mesothelin monoclonal antibodies
|
|
KR20100135312A
(ko)
|
2008-04-24 |
2010-12-24 |
디 오스트레일리언 내셔널 유니버시티 |
합성 중합체의 방사성 표지화 방법
|
|
US20090297439A1
(en)
|
2008-06-02 |
2009-12-03 |
Metheresis Translational Research Sa, |
Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits
|
|
WO2010016766A2
(en)
|
2008-08-08 |
2010-02-11 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Antibodies recognizing endogenous human lgr5 and/or lgr6
|
|
MX2011002837A
(es)
|
2008-09-19 |
2011-07-29 |
Medimmune Llc |
Anticuerpos dirigidos al ligando tipo delta 4 (dll4) y usos de los mismos.
|
|
EP2356270B1
(en)
|
2008-11-07 |
2016-08-24 |
Fabrus Llc |
Combinatorial antibody libraries and uses thereof
|
|
EP2396034A4
(en)
|
2009-02-10 |
2012-11-21 |
Shenogen Pharma Group Ltd |
ANTIBODIES AND METHODS FOR TREATING DISEASES ASSOCIATED WITH A STROGEN RECEPTOR
|
|
AU2010230063B2
(en)
|
2009-03-24 |
2015-06-25 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Anti-mesothelin antibodies
|
|
US20100279301A1
(en)
|
2009-05-04 |
2010-11-04 |
The Regents Of The University Of Michigan |
Methods and compositions for diagnosing bladder cancer
|
|
GB2472856B
(en)
|
2009-08-21 |
2012-07-11 |
Cantargia Ab |
IL1-RAP modulators and uses thereof
|
|
GB0922434D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
antibodies and fragments thereof
|
|
CN102167742B
(zh)
|
2010-02-25 |
2014-05-14 |
上海百迈博制药有限公司 |
一种全人源抗her2单克隆抗体、其制备方法及用途
|
|
RU2613886C2
(ru)
|
2010-06-03 |
2017-03-21 |
Дженентек, Инк. |
Антитела и иммуноконъюгаты, визуализируемые при помощи иммуно-позитрон-эмиссионной томографии, и способы их применения
|
|
CA2806076A1
(en)
|
2010-07-22 |
2012-01-26 |
The Regents Of The University Of California |
Anti-tumor antigen antibodies and methods of use
|
|
UA112062C2
(uk)
|
2010-10-04 |
2016-07-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Cd33-зв'язувальний агент
|
|
UA115641C2
(uk)
|
2010-12-20 |
2017-11-27 |
Дженентек, Інк. |
Виділене антитіло, яке зв'язує мезотелін, та імунокон'югат, що його містить
|
|
EP3508498A1
(en)
|
2011-01-19 |
2019-07-10 |
Cantargia AB |
Novel agents and uses thereof
|
|
BR112013021863A2
(pt)
|
2011-03-03 |
2016-11-22 |
Apexigen Inc |
anticorpos anti-receptor il-6 e métodos de uso
|
|
WO2012158960A2
(en)
|
2011-05-17 |
2012-11-22 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Melanocortin 1 receptor ligands and methods of use
|
|
WO2013010573A1
(en)
|
2011-07-18 |
2013-01-24 |
Universitaet Muenster |
Compounds with matrix-metalloproteinase inhibitory activity
|
|
MX2013013627A
(es)
|
2011-06-21 |
2014-04-25 |
Oncofactor Corp |
Composiciones y metodos para la terapia y diagnostico de cancer.
|
|
CA2840409A1
(en)
|
2011-06-28 |
2013-01-03 |
Whitehead Institute For Biomedical Research |
Using sortases to install click chemistry handles for protein ligation
|
|
CA2845536A1
(en)
|
2011-08-15 |
2013-02-21 |
Amplimmune, Inc. |
Anti-b7-h4 antibodies and their uses
|
|
WO2013028907A1
(en)
|
2011-08-23 |
2013-02-28 |
Infinity Pharmaceuticals, Inc. |
Biomarkers predictive of therapeutic responsiveness to hsp90 inhibitors and uses thereof
|
|
CA2853705C
(en)
|
2011-10-25 |
2021-10-12 |
Memorial Sloan-Kettering Cancer Center |
Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
|
|
ES2601459T3
(es)
|
2011-10-28 |
2017-02-15 |
Fredax Ab |
Agentes terapéuticos y usos de los mismos
|
|
US20140322216A1
(en)
|
2011-11-08 |
2014-10-30 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
JP6397765B2
(ja)
|
2011-11-11 |
2018-09-26 |
ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
プロテアソーム阻害剤に応答するバイオマーカー
|
|
CA2860528A1
(en)
|
2012-01-06 |
2013-07-11 |
Linxis B.V. |
Method for preparing cell targeting conjugates using functional metal ion constructs
|
|
WO2013138696A1
(en)
|
2012-03-16 |
2013-09-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Zirconium-89 complexes, methods of labeling cells, labeled cells, kits, and methods of use thereof
|
|
AR090549A1
(es)
|
2012-03-30 |
2014-11-19 |
Genentech Inc |
Anticuerpos anti-lgr5 e inmunoconjugados
|
|
CA2870485A1
(en)
|
2012-04-13 |
2013-10-17 |
Whitehead Institute For Biomedical Research |
Sortase-modified vhh domains and uses thereof
|
|
WO2013158841A1
(en)
|
2012-04-18 |
2013-10-24 |
The Regents Of The University Of California |
Peptide mimotopes to oxidation specific epitopes
|
|
AR090903A1
(es)
|
2012-05-01 |
2014-12-17 |
Genentech Inc |
Anticuerpos e inmunoconjugados anti-pmel17
|
|
US9163090B2
(en)
|
2012-05-07 |
2015-10-20 |
Cellerant Therapeutics, Inc. |
Antibodies specific for CLL-1
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
AR091098A1
(es)
|
2012-05-21 |
2015-01-14 |
Genentech Inc |
ANTICUERPOS E INMUNOCONJUGADOS CONTRA Ly6E Y METODOS DE USO
|
|
DE102012104504B4
(de)
|
2012-05-24 |
2021-10-07 |
Bundesrepublik Deutschland, vertreten durch das Bundesministerium für Wirtschaft und Technologie, dieses vertreten durch den Präsidenten der BAM, Bundesanstalt für Materialforschung und -prüfung |
Polypeptidmarker
|
|
WO2014025828A1
(en)
|
2012-08-06 |
2014-02-13 |
The Regents Of The University Of California |
Engineered antibody fragments for targeting and imaging cd8 expression in vivo
|
|
CN103736092A
(zh)
|
2012-08-09 |
2014-04-23 |
清华大学 |
抑制新生淋巴管生成的方法和药物
|
|
CN104704359A
(zh)
|
2012-10-25 |
2015-06-10 |
生命科技公司 |
糖蛋白酶介导位点特异性放射性标记的方法和组合物
|
|
EP2740726A1
(en)
|
2012-12-07 |
2014-06-11 |
3B Pharmaceuticals GmbH |
Neurotensin receptor ligands
|
|
TWI635098B
(zh)
|
2013-02-01 |
2018-09-11 |
再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
ES2673583T3
(es)
|
2013-02-28 |
2018-06-22 |
National Cancer Center |
Anticuerpo contra fibrina insoluble
|
|
CN113045660B
(zh)
|
2013-03-13 |
2023-09-01 |
伊麦吉纳博公司 |
与cd8的抗原结合构建体
|
|
CN105307685B
(zh)
|
2013-03-13 |
2019-03-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
AU2014244424A1
(en)
|
2013-03-14 |
2015-08-27 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
|
US20160000946A1
(en)
|
2013-03-14 |
2016-01-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma
|
|
US9562099B2
(en)
|
2013-03-14 |
2017-02-07 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
|
US9511350B2
(en)
|
2013-05-10 |
2016-12-06 |
Clean Diesel Technologies, Inc. (Cdti) |
ZPGM Diesel Oxidation Catalysts and methods of making and using same
|
|
EP3008212A4
(en)
|
2013-06-10 |
2017-05-24 |
Millennium Pharmaceuticals, Inc. |
Methods of treatment of cancer
|
|
DE102013106066A1
(de)
|
2013-06-11 |
2014-12-11 |
Johannes-Gutenberg-Universität Mainz |
Bifunktionelle Chelatbildner auf der Basis des 1,4-Diazepin-Gerüsts (DAZA) für die nicht invasive molekulare Bilddarstellung
|
|
TWI725931B
(zh)
|
2013-06-24 |
2021-05-01 |
美商建南德克公司 |
抗ｆｃｒｈ５抗體
|
|
FR3008408B1
(fr)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
US9475874B2
(en)
|
2013-08-26 |
2016-10-25 |
MabVax Therapeutics, Inc. |
Nucleic acids encoding human antibodies to sialyl-lewisa
|
|
MX2016004853A
(es)
|
2013-10-21 |
2016-07-19 |
Genentech Inc |
Metodos de uso de anticuerpos anti-ly6e.
|
|
US10556024B2
(en)
|
2013-11-13 |
2020-02-11 |
Whitehead Institute For Biomedical Research |
18F labeling of proteins using sortases
|
|
LT3071595T
(lt)
|
2013-11-19 |
2019-05-10 |
Fredax Ab |
Humanizuotas anti-kalikreino-2 antikūnas
|
|
AU2014362238A1
(en)
|
2013-12-13 |
2016-06-09 |
Genentech, Inc. |
Anti-CD33 antibodies and immunoconjugates
|
|
TWI680138B
(zh)
*
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗ｐｄ-ｌ１之人類抗體
|
|
TWI681969B
(zh)
*
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對ｐｄ-１的人類抗體
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
DK3131585T3
(da)
|
2014-03-19 |
2020-10-19 |
Univ Zuerich |
Multidentate, bifunktionelle chelateringsmidler til radionuklidkompleksdannelse i diagnostik og terapi
|
|
MX2016015162A
(es)
|
2014-05-22 |
2017-03-03 |
Genentech Inc |
Anticuerpos anti - gpc3 e inmunoconjugados.
|
|
WO2015188934A1
(en)
|
2014-06-10 |
2015-12-17 |
3B Pharmaceuticals Gmbh |
Conjugate comprising a neurotensin receptor ligand and use thereof
|
|
WO2015191715A1
(en)
|
2014-06-11 |
2015-12-17 |
Genentech, Inc. |
Anti-lgr5 antibodies and uses thereof
|
|
DK3157956T3
(da)
*
|
2014-06-19 |
2020-04-27 |
Regeneron Pharma |
Ikke-humane dyr med et humaniseret gen med programmeret celledød 1
|
|
GB201413913D0
(en)
|
2014-08-06 |
2014-09-17 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
EP3177640B1
(en)
|
2014-08-08 |
2020-05-06 |
The Board of Trustees of the Leland Stanford Junior University |
High affinity pd-1 agents and methods of use
|
|
CN113698485A
(zh)
|
2014-09-12 |
2021-11-26 |
基因泰克公司 |
抗-b7-h4抗体及免疫缀合物
|
|
CN107001479B
(zh)
|
2014-09-12 |
2021-09-28 |
基因泰克公司 |
抗her2抗体和免疫缀合物
|
|
CA2958479A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Anti-cll-1 antibodies and immunoconjugates
|
|
WO2016058056A1
(en)
|
2014-10-16 |
2016-04-21 |
The University Of Melbourne |
Novel imaging composition and uses thereof
|
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
DK3221363T3
(da)
|
2014-11-21 |
2020-08-10 |
Bristol Myers Squibb Co |
Antistoffer mod cd73 og anvendelser deraf
|
|
EP3224277B1
(en)
|
2014-11-25 |
2020-08-26 |
Bristol-Myers Squibb Company |
Novel pd-l1 binding polypeptides for imaging
|
|
EP4399969A3
(en)
|
2014-12-09 |
2024-10-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a humanized cluster of differentiation 274 gene
|
|
US11534506B2
(en)
|
2015-03-06 |
2022-12-27 |
Mayo Foundation For Medical Education And Research |
Methods for cell labeling and medical imaging
|
|
NL2014423B1
(en)
|
2015-03-09 |
2016-10-13 |
Linxis B V |
Method for removing weakly bound functional moieties from cell targeting conjugates.
|
|
WO2016162368A1
(en)
*
|
2015-04-07 |
2016-10-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Non-invasive imaging of tumor pd-l1 expression
|
|
US10806808B2
(en)
|
2015-05-22 |
2020-10-20 |
Memorial Sloan Kettering Cancer Center |
Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
|
|
US12048753B2
(en)
|
2015-10-01 |
2024-07-30 |
Whitehead Institute For Biomedical Research |
Labeling of antibodies
|
|
EP3377117A1
(en)
|
2015-11-18 |
2018-09-26 |
Memorial Sloan Kettering Cancer Center |
Systems, methods, and compositions for imaging androgen receptor axis activity in carcinoma, and related therapeutic compositions and methods
|
|
MX2018014028A
(es)
|
2016-05-19 |
2019-04-04 |
Squibb Bristol Myers Co |
Inmunomoduladores de produccion de imagenes de tomografia por emision de positrones (pet).
|
|
US20190298846A1
(en)
|
2016-06-06 |
2019-10-03 |
Linxis B.V. |
Cell targeting conjugates
|
|
AU2017281940C1
(en)
|
2016-06-24 |
2024-11-07 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
EP3266465A1
(en)
|
2016-07-06 |
2018-01-10 |
Julius-Maximilians-Universität Würzburg |
Immune complexes
|
|
US11633506B2
(en)
|
2016-07-18 |
2023-04-25 |
Wisconsin Alumni Research Foundation |
Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies
|
|
KR102396334B1
(ko)
|
2016-07-18 |
2022-05-09 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인 시츄 면역 조절 암 백신화를 위한 방사성할로겐화 제제
|
|
US11168148B2
(en)
|
2016-09-07 |
2021-11-09 |
The Regents Of The University Of California |
Antibodies to oxidation-specific epitopes
|
|
WO2018058125A1
(en)
|
2016-09-26 |
2018-03-29 |
Ensemble Group Holdings |
Methods of assessing and treating cancer in subjects having dysregulated lymphatic systems
|
|
WO2018128664A2
(en)
|
2016-10-20 |
2018-07-12 |
The University Of North Carolina At Chapel Hill |
18f-labeled compounds for pet imaging and uses thereof
|
|
EP3565555A4
(en)
|
2016-11-07 |
2021-03-17 |
VIDAC Pharma Ltd. |
USE OF HEXOKINASE 2 / MITOCHONDRIA DETACHMENT COMPOUNDS FOR THE TREATMENT OF HEXOKINASE 2 (HK2) EXPRESSING CANCERS
|
|
EP3548515A1
(en)
|
2016-12-01 |
2019-10-09 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
|